This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pollack, M. S. Articles by Whitmore, W. F. Search for Related Content PubMed PubMed Citation Articles by Pollack, M. S. Articles by Whitmore, W. F., Jr.

HLA Antigens in Patients with Germ Cell Cancers of the Testis¹

Tissue Typing Laboratory [M. S. P., B. D.], Solid Tumor Service [D. V.], and Urology Service [W. H., H. W. H., W. F. W.], Memorial Sloan-Kettering, Cancer Center, New York, New York 10021

The expression of HLA-A, -B, -C, and -DR antigens has been analyzed in 145 unrelated Caucasian patients with germ cell tumors of the testis. Eighteen of these patients had pure seminoma, while the remaining patients had nonseminomatous tumors with embryonal carcinoma, teratocarcinoma, choriocarcinoma, and/or yolk sac components, with or without seminoma. Increases were noted in the frequencies of Aw33, B5, DR5, and DRw6 among the patients with pure seminoma, A3 and B7 among the patients with embryonal carcinoma with or without seminoma, and Aw32 among the patients with yolk sac tumor components. A decrease in the frequency of HLA-DR3 was noted in all patient subgroups, although none of these differences were statistically significant after correction for the number of antigens tested. HLA typing results for three affected brothers of patients indicate that, in each family, the affected sibling pair share at least one HLA haplotype. The etiological and prognostic significance of this finding and of the increases in a few HLA antigen frequencies in particular patient groups and the overall decrease in DR3 remain to be determined.

¹ Supported in part by NIH Grants CA-08748 and CA-22507.

² To whom requests for reprints should be addressed.

Received 7/27/81. Accepted 2/ 8/82.